This is the first study to describe the capacity of RL leaf SC-CO2 extracts to inhibit enzymes related to inflammation (XO, LOX, hyaluronidase) and diabetes (α -amylase, α-glucosidase). The gene discussed is XDH; the disease is diabetes mellitus.